INVO Fertility, Inc. (IVF)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Elimination of Intersegment Revenue	-29.00K	-
INVO Cell Device	110.57K	158.00K
INVO Cell Device Growth	-30.02%	-
Fertility Clinic Services	6.45M	2.86M
Fertility Clinic Services Growth	125.34%	-
Total	6.53M	3.02M
Total Growth	116.25%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	6.53M	3.02M
United States Growth	116.25%	-
Total	6.53M	3.02M
Total Growth	116.25%	-

Source: S&P Global Market Intelligence.